Filter
1286
Filtered Results: 1286
Text search:
immunity
Featured
Recommendations
140
New Publications
285
Language
Document type
No document type
586
Guidelines
231
Studies & Reports
211
Manuals
66
Fact sheets
66
Strategic & Response Plan
52
Training Material
35
Situation Updates
17
Videos
8
Resource Platforms
7
Online Courses
3
Brochures
2
Infographics
2
Countries / Regions
India
74
Global
62
Kenya
31
Latin America and the Carribbean
28
Africa
28
South Africa
27
Nigeria
24
Ethiopia
21
Brazil
19
Tanzania
18
Middle East and North Africa
18
West and Central Africa
16
Western and Central Europe
16
Rwanda
15
East and Southern Africa
14
Sierra Leone
13
Nepal
12
Bangladesh
12
Venezuela
12
Russia
12
Liberia
11
Congo, Democratic Republic of
11
Germany
11
Syria
11
Malawi
11
Ukraine
11
Myanmar / Burma
11
Ghana
10
Namibia
10
South–East Asia Region
10
Uganda
9
Philippines
9
Eastern Europe
9
Zimbabwe
8
Pakistan
8
Yemen
8
Somalia
7
Cambodia
7
Mozambique
7
Lesotho
7
Haiti
6
South Sudan
6
Lebanon
6
Zambia
6
Vietnam
6
Senegal
5
Afghanistan
5
China
5
Indonesia
5
Argentina
5
Burkina Faso
4
Asia
4
Guinea
3
Cameroon
3
Iraq
3
Thailand
3
Peru
3
Chile
3
United Kingdom
3
Spain
3
Mali
2
Morocco
2
Saudi Arabia
2
Niger
2
Jordan
2
Turkey
2
Papua New Guinea
2
Sudan
2
Colombia
2
Ecuador
2
Botswana
2
Angola
2
Mexico
2
Western Pacific Region
2
Albania
2
Laos
2
France
2
Tunisia
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Egypt
1
Chad
1
Malaysia
1
Mauritania
1
Singapore
1
Benin
1
Central African Republic
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Honduras
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
Guatemala
1
Madagascar
1
Nicaragua
1
Sri Lanka
1
Other region
1
Bhutan
1
North Korea
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Kazakhstan
1
Georgia
1
North America
1
Japan
1
Mauritius
1
Portugal
1
South Korea
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
443
Clinical Guidelines
177
Public Health
73
Women & Child Health
59
Key Resources
35
Pharmacy & Technologies
19
Capacity Building
16
Annual Report MEDBOX
1
Toolboxes
COVID-19
293
Rapid Response
89
TB
85
NTDs
64
HIV
55
Polio
45
Planetary Health
31
Ebola
30
AMR
26
Refugee
24
Cholera
21
Conflict
21
Mental Health
21
Caregiver
18
Zika
17
Global Health Education
15
NCDs
15
Pharmacy
8
Natural Hazards
7
Health Financing Toolbox
6
Disability
5
Specific Hazards
4
Typhoon
1
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 ... from natural infection. More information about considerations on vaccine certificates or “passports” will be covered in an update of WHO interim guidance, as requested by the COVID-19 emergency committee.
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
The Lancet, Early Online Publication, 11 July 2014
doi:10.1016/S0140-6736(14)60934-X
*Free registration is required to view this article
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin Americ...
Natural immunity against COVID-19
Scientific report 10 May 2021
Vaccines are designed to give you immunity without the dangers of getting the disease. It’s common to experience some mild to moderate side effects when receiving vaccinations. This is because your immune system instructs your body to increase blo...
Elderly people are at a higher risk of COVID-19 infection due to their decreased immunity and body reserves, as well as multiple associated comorbidities like diabetes, hypertension, chronic kidney disease and chronic obstructive pulmonary disease. ...
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that polici...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics ...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational...
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s previous volume—and over 2.7 million deaths attrib...
COVID-19 is a pandemic that is currently ravaging the world. Infection rate is steadily increasingin Sub-Saharan Africa. Pregnant women and their infants may suffer severe illnesses due to theirlower immunity. This guideline prepares and equips clin...
There are currently 4 different serotypes of Dengue virus known to science. Each time someone get infected and recovers, the individual will be protected by a lifelong immunity from further infection against that specific serotype and that serotype ...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be v...
Vaccines contribute to the battle against antimicrobial resistance (AMR) by preventing infections and thereby reducing antimicrobial use and the incidence of disease from resistant pathogens. By preventing infection transmission, vaccines extend population protection by also reducing the risk of inf...
In where under-five mortality is high and vitamin A deficiency is a public health problem, two high-dose supplements of vitamin A per year, spaced four to six months apart, can strengthen children’s immune systems and improve their chances of survival.
During much of early childhood – from...
During much of early childhood – from...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired ..., including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
